Healthcare Sector Stocks
The Healthcare sector has a total of 1050 stocks, with a combined market cap of $9.23 trillion, total revenue of $4.67 trillion and a weighted average PE ratio of 48.32.
Market Cap
9.23T
Revenue
4.67T
Profits
190.99B
PE Ratio
48.32
Profit Margin
4.09%
Dividend Yield
0.39%
1049 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.05T | 0.83% | 1,392,910 | 79.67B |
| 2 | JNJ | Johnson & Johnson | 630.04B | 1.93% | 5,727,278 | 97.93B |
| 3 | ABBV | AbbVie Inc. | 488.55B | 1.49% | 4,297,754 | 64.39B |
| 4 | MRK | Merck & Co., Inc. | 359.22B | 2.26% | 9,288,038 | 66.57B |
| 5 | UNH | UnitedHealth Group Incorporated | 340.46B | 2.25% | 7,467,985 | 450.53B |
| 6 | NVS | Novartis AG | 272.48B | 0.45% | 1,901,063 | 56.69B |
| 7 | AZN | AstraZeneca PLC | 246.25B | 0.26% | 2,121,760 | 61.37B |
| 8 | TMO | Thermo Fisher Scientific Inc. | 243.30B | 0.93% | 1,580,678 | 46.34B |
| 9 | AMGN | Amgen Inc. | 224.29B | 1.82% | 2,553,134 | 38.10B |
| 10 | GILD | Gilead Sciences, Inc. | 187.44B | 2.77% | 5,802,156 | 30.46B |
| 11 | ABT | Abbott Laboratories | 172.35B | 1.13% | 6,961,958 | 46.59B |
| 12 | NVO | Novo Nordisk A/S | 169.11B | 1.20% | 9,645,389 | 50.34B |
| 13 | PFE | Pfizer Inc. | 161.19B | 1.65% | 23,204,132 | 63.70B |
| 14 | DHR | Danaher Corporation | 154.52B | 1.08% | 3,934,416 | 25.11B |
| 15 | ISRG | Intuitive Surgical, Inc. | 149.78B | 2.06% | 1,762,079 | 11.03B |
| 16 | VRTX | Vertex Pharmaceuticals Incorporated | 129.29B | 1.36% | 1,480,840 | 12.59B |
| 17 | BMY | Bristol-Myers Squibb Company | 120.77B | -0.77% | 9,253,462 | 49.19B |
| 18 | MDT | Medtronic plc | 113.18B | 0.83% | 38,912,078 | 37.54B |
| 19 | CVS | CVS Health Corporation | 110.20B | -1.87% | 11,652,302 | 412.65B |
| 20 | MCK | McKesson Corporation | 109.46B | 0.92% | 482,915 | 410.98B |
| 21 | SYK | Stryker Corporation | 106.38B | 0.13% | 1,476,516 | 25.84B |
| 22 | HCA | HCA Healthcare, Inc. | 97.66B | 1.37% | 981,150 | 78.01B |
| 23 | SNY | Sanofi | 95.94B | -0.40% | 2,102,609 | 55.89B |
| 24 | GSK | GSK plc | 92.79B | -0.09% | 8,542,746 | 44.05B |
| 25 | MRNA | Moderna, Inc. | 89.83B | 14.21% | 28,947,265 | 2.23B |
| 26 | ELV | Elevance Health, Inc. | 89.50B | 2.93% | 2,077,033 | 201.11B |
| 27 | CI | The Cigna Group | 74.63B | 0.50% | 885,419 | 282.38B |
| 28 | REGN | Regeneron Pharmaceuticals, Inc. | 74.55B | 0.94% | 466,001 | 15.53B |
| 29 | BSX | Boston Scientific Corporation | 61.93B | 1.64% | 13,037,394 | 21.00B |
| 30 | COR | Cencora, Inc. | 61.80B | 0.78% | 781,943 | 332.77B |
| 31 | TAK | Takeda Pharmaceutical Company Limited | 58.92B | 1.13% | 2,043,469 | 28.42B |
| 32 | NTRA | Natera, Inc. | 57.76B | 2.54% | 1,010,940 | 2.71B |
| 33 | CAH | Cardinal Health, Inc. | 55.01B | -0.58% | 1,028,179 | 254.25B |
| 34 | HUM | Humana Inc. | 51.86B | 11.56% | 4,993,488 | 145.68B |
| 35 | ARGX | argenx SE | 51.01B | 0.78% | 511,021 | 5.32B |
| 36 | BDX | Becton, Dickinson and Company | 50.05B | 0.55% | 1,615,715 | 22.48B |
| 37 | EW | Edwards Lifesciences Corporation | 49.12B | 1.15% | 3,890,502 | 6.51B |
| 38 | A | Agilent Technologies, Inc. | 48.08B | 1.41% | 1,537,412 | 7.37B |
| 39 | VEEV | Veeva Systems Inc. | 47.95B | 3.96% | 1,848,938 | 3.46B |
| 40 | TEVA | Teva Pharmaceutical Industries Limited | 47.89B | 4.71% | 14,822,347 | 17.32B |
| 41 | MDLN | Medline Inc. | 47.67B | 1.45% | 5,333,690 | 29.94B |
| 42 | IQV | IQVIA Holdings Inc. | 42.78B | 0.39% | 972,341 | 16.98B |
| 43 | WAT | Waters Corporation | 42.62B | 1.08% | 1,119,546 | 4.64B |
| 44 | ILMN | Illumina, Inc. | 42.00B | 5.14% | 1,894,520 | 4.49B |
| 45 | IDXX | IDEXX Laboratories, Inc. | 40.81B | 0.95% | 466,780 | 4.55B |
| 46 | HLN | Haleon plc | 40.71B | 0.65% | 11,304,657 | 14.80B |
| 47 | RVMD | Revolution Medicines, Inc. | 40.67B | 0.87% | 2,210,444 | - |
| 48 | ONC | BeOne Medicines AG | 40.30B | 1.24% | 318,333 | 6.13B |
| 49 | BIIB | Biogen Inc. | 33.35B | 3.33% | 814,920 | 10.03B |
| 50 | RPRX | Royalty Pharma plc | 32.73B | 1.28% | 2,691,105 | 2.54B |
| 51 | RMD | ResMed Inc. | 32.35B | 1.46% | 1,003,237 | 5.65B |
| 52 | CNC | Centene Corporation | 32.29B | 1.27% | 2,853,184 | 180.30B |
| 53 | DXCM | DexCom, Inc. | 31.74B | -0.36% | 3,149,843 | 4.97B |
| 54 | ALNY | Alnylam Pharmaceuticals, Inc. | 31.13B | 3.63% | 859,782 | 4.80B |
| 55 | MTD | Mettler-Toledo International Inc. | 31.06B | 1.34% | 180,649 | 4.13B |
| 56 | ALC | Alcon Inc. | 30.92B | 1.55% | 1,345,877 | 10.86B |
| 57 | ZTS | Zoetis Inc. | 30.91B | 2.37% | 2,912,271 | 9.53B |
| 58 | GEHC | GE HealthCare Technologies Inc. | 29.69B | 2.37% | 2,856,926 | 21.27B |
| 59 | WST | West Pharmaceutical Services, Inc. | 25.76B | 0.75% | 480,215 | 3.33B |
| 60 | ROIV | Roivant Sciences Ltd. | 25.60B | 3.60% | 5,530,231 | 7.53M |
| 61 | DGX | Quest Diagnostics Incorporated | 25.49B | 0.07% | 775,451 | 11.56B |
| 62 | LH | Labcorp Holdings Inc. | 25.32B | -0.65% | 607,865 | 14.35B |
| 63 | BNTX | BioNTech SE | 24.36B | 5.32% | 1,320,366 | 3.03B |
| 64 | PHG | Koninklijke Philips N.V. | 23.84B | -0.25% | 3,330,716 | 20.18B |
| 65 | UTHR | United Therapeutics Corporation | 23.55B | 3.07% | 577,860 | 3.15B |
| 66 | INCY | Incyte Corporation | 22.86B | 0.04% | 1,121,728 | 5.82B |
| 67 | GH | Guardant Health, Inc. | 22.47B | 1.15% | 1,519,910 | 1.18B |
| 68 | INSM | Insmed Incorporated | 21.97B | 0.12% | 2,474,261 | 1.14B |
| 69 | GMAB | Genmab A/S | 21.89B | 2.83% | 2,333,434 | 4.13B |
| 70 | THC | Tenet Healthcare Corporation | 21.24B | 1.23% | 525,310 | 21.81B |
| 71 | STE | STERIS plc | 20.90B | 1.73% | 597,024 | 6.04B |
| 72 | VTRS | Viatris Inc. | 20.26B | 1.15% | 8,831,000 | 14.74B |
| 73 | RVTY | Revvity, Inc. | 17.20B | 1.33% | 1,224,322 | 2.91B |
| 74 | MEDP | Medpace Holdings, Inc. | 17.08B | 1.55% | 159,763 | 2.78B |
| 75 | ZBH | Zimmer Biomet Holdings, Inc. | 17.00B | 0.29% | 1,604,255 | 8.51B |
| 76 | ASND | Ascendis Pharma A/S | 15.05B | 2.94% | 815,733 | 1.20B |
| 77 | SOLV | Solventum Corporation | 14.86B | 1.02% | 1,297,416 | 8.31B |
| 78 | EXEL | Exelixis, Inc. | 14.83B | 1.42% | 2,665,748 | 2.44B |
| 79 | NBIX | Neurocrine Biosciences, Inc. | 14.48B | 0.84% | 1,019,508 | 3.37B |
| 80 | CRL | Charles River Laboratories International, Inc. | 14.41B | 1.27% | 679,856 | 4.00B |
| 81 | JAZZ | Jazz Pharmaceuticals plc | 14.18B | -1.81% | 1,288,280 | 4.60B |
| 82 | SMMT | Summit Therapeutics Inc. | 14.07B | 2.45% | 5,755,325 | - |
| 83 | BTSG | BrightSpring Health Services, Inc. | 13.28B | 0.13% | 1,614,409 | 14.37B |
| 84 | CORT | Corcept Therapeutics Incorporated | 13.10B | 2.24% | 624,208 | 830.81M |
| 85 | TEM | Tempus AI, Inc. | 12.80B | 2.38% | 6,273,311 | 1.43B |
| 86 | BBIO | BridgeBio Pharma, Inc. | 12.78B | 0.48% | 1,846,372 | 713.07M |
| 87 | ICLR | ICON Public Limited Company | 12.67B | -0.20% | 745,620 | 8.29B |
| 88 | BAX | Baxter International Inc. | 12.59B | 1.88% | 3,011,407 | 11.47B |
| 89 | PEN | Penumbra, Inc. | 12.58B | 0.59% | 555,294 | 1.50B |
| 90 | HALO | Halozyme Therapeutics, Inc. | 12.53B | 0.53% | 1,845,099 | 1.66B |
| 91 | EHC | Encompass Health Corporation | 12.17B | 0.64% | 604,383 | 6.21B |
| 92 | ELAN | Elanco Animal Health Incorporated | 11.45B | 1.69% | 2,520,125 | 5.02B |
| 93 | DVA | DaVita Inc. | 11.43B | 1.26% | 369,637 | 14.01B |
| 94 | TECH | Bio-Techne Corporation | 11.36B | 0.01% | 2,182,570 | 1.22B |
| 95 | SNN | Smith & Nephew plc | 11.36B | 1.04% | 982,901 | 6.30B |
| 96 | IBRX | ImmunityBio, Inc. | 11.14B | 6.05% | 18,657,505 | 165.79M |
| 97 | FMS | Fresenius Medical Care AG | 11.13B | 0.86% | 1,011,663 | 22.19B |
| 98 | MDGL | Madrigal Pharmaceuticals, Inc. | 10.90B | -1.08% | 312,959 | 1.28B |
| 99 | PCVX | Vaxcyte, Inc. | 10.62B | 9.78% | 4,380,935 | - |
| 100 | BMRN | BioMarin Pharmaceutical Inc. | 10.61B | -0.17% | 2,146,364 | 3.41B |
| 101 | AVTR | Avantor, Inc. | 10.60B | 1.82% | 4,244,050 | 6.56B |
| 102 | TXG | 10x Genomics, Inc. | 10.51B | 4.36% | 3,684,933 | 616.91M |
| 103 | UHS | Universal Health Services, Inc. | 10.45B | 0.93% | 397,329 | 18.11B |
| 104 | COO | The Cooper Companies, Inc. | 10.34B | 0.13% | 3,179,612 | 4.24B |
| 105 | OSCR | Oscar Health, Inc. | 10.29B | 0.82% | 5,322,713 | 15.32B |
| 106 | RDY | Dr. Reddy's Laboratories Limited | 10.29B | 2.30% | 1,972,311 | 3.50B |
| 107 | MOH | Molina Healthcare, Inc. | 10.26B | 0.60% | 509,219 | 42.47B |
| 108 | ALGN | Align Technology, Inc. | 10.14B | 1.19% | 1,079,153 | 4.14B |
| 109 | GMED | Globus Medical, Inc. | 10.02B | 1.80% | 1,078,651 | 3.14B |
| 110 | TWST | Twist Bioscience Corporation | 10.02B | 5.08% | 3,540,107 | 431.80M |
| 111 | ENSG | The Ensign Group, Inc. | 9.93B | 0.18% | 205,299 | 5.49B |
| 112 | KRYS | Krystal Biotech, Inc. | 9.82B | 1.32% | 196,947 | 440.48M |
| 113 | RGEN | Repligen Corporation | 9.81B | 6.13% | 1,340,010 | 785.10M |
| 114 | BIO | Bio-Rad Laboratories, Inc. | 9.79B | 1.60% | 138,976 | 2.59B |
| 115 | GKOS | Glaukos Corporation | 9.77B | 2.73% | 1,196,008 | 612.84M |
| 116 | QGEN | Qiagen N.V. | 9.38B | 1.91% | 1,255,475 | 2.10B |
| 117 | PODD | Insulet Corporation | 9.38B | 0.60% | 865,357 | 3.05B |
| 118 | HSIC | Henry Schein, Inc. | 9.36B | -0.73% | 1,087,373 | 13.60B |
| 119 | KYMR | Kymera Therapeutics, Inc. | 9.35B | 2.84% | 1,305,176 | 105.00M |
| 120 | PTGX | Protagonist Therapeutics, Inc. | 9.30B | 2.73% | 763,092 | 281.99M |
| 121 | BRKR | Bruker Corporation | 8.96B | 1.59% | 1,465,522 | 3.50B |
| 122 | ARWR | Arrowhead Pharmaceuticals, Inc. | 8.86B | 3.31% | 2,764,864 | 669.50M |
| 123 | AXSM | Axsome Therapeutics, Inc. | 8.82B | -1.02% | 894,483 | 776.57M |
| 124 | CYTK | Cytokinetics, Incorporated | 8.75B | 1.45% | 1,118,074 | 67.67M |
| 125 | CAI | Caris Life Sciences, Inc. | 8.39B | 8.00% | 5,033,907 | 989.61M |
| 126 | HNGE | Hinge Health, Inc. | 8.30B | 5.00% | 1,702,729 | 720.06M |
| 127 | SYRE | Spyre Therapeutics, Inc. | 8.01B | 7.25% | 1,116,433 | - |
| 128 | TGTX | TG Therapeutics, Inc. | 7.85B | 3.81% | 1,621,420 | 799.54M |
| 129 | ABVX | ABIVAX Société Anonyme | 7.71B | -1.01% | 885,318 | 5.33M |
| 130 | HQY | HealthEquity, Inc. | 7.66B | -0.47% | 555,899 | 1.36B |
| 131 | ATR | AptarGroup, Inc. | 7.65B | -1.17% | 542,172 | 3.93B |
| 132 | IONS | Ionis Pharmaceuticals, Inc. | 7.52B | 4.57% | 4,862,316 | 874.09M |
| 133 | PRAX | Praxis Precision Medicines, Inc. | 7.26B | -1.40% | 517,222 | 7.46M |
| 134 | HIMS | Hims & Hers Health, Inc. | 7.21B | 10.19% | 16,031,709 | 2.58B |
| 135 | AMRX | Amneal Pharmaceuticals, Inc. | 6.93B | 1.32% | 2,087,305 | 3.12B |
| 136 | PACS | PACS Group, Inc. | 6.86B | -0.98% | 763,842 | 5.55B |
| 137 | ALKS | Alkermes plc | 6.81B | 1.25% | 1,626,913 | 1.67B |
| 138 | IOVA | Iovance Biotherapeutics, Inc. | 6.62B | 9.84% | 16,990,230 | 324.97M |
| 139 | GRFS | Grifols, S.A. | 6.62B | 0.67% | 330,560 | 8.48B |
| 140 | LNTH | Lantheus Holdings, Inc. | 6.54B | 0.03% | 973,530 | 1.56B |
| 141 | CHE | Chemed Corporation | 6.51B | 0.32% | 134,464 | 2.60B |
| 142 | IMVT | Immunovant, Inc. | 6.29B | 0.69% | 1,494,818 | - |
| 143 | GRAL | GRAIL, Inc. | 6.28B | 6.01% | 774,108 | 165.26M |
| 144 | KOD | Kodiak Sciences Inc. | 6.26B | 5.95% | 1,735,327 | - |
| 145 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.25B | 1.27% | 1,411,378 | 239.92M |
| 146 | KNSA | Kiniksa Pharmaceuticals International, plc | 6.22B | 1.31% | 430,274 | 840.85M |
| 147 | BLTE | Belite Bio, Inc | 6.22B | 1.29% | 179,300 | - |
| 148 | BLCO | Bausch + Lomb Corporation | 6.18B | 0.87% | 234,318 | 5.32B |
| 149 | LGND | Ligand Pharmaceuticals Incorporated | 6.02B | 2.31% | 183,009 | 290.54M |
| 150 | CGON | CG Oncology, Inc. | 5.66B | 0.89% | 516,328 | 6.23M |
| 151 | ERAS | Erasca, Inc. | 5.61B | 3.69% | 7,771,530 | - |
| 152 | MIRM | Mirum Pharmaceuticals, Inc. | 5.58B | 5.73% | 1,139,627 | 618.07M |
| 153 | RDNT | RadNet, Inc. | 5.58B | 3.96% | 507,433 | 2.27B |
| 154 | MMED | MiniMed Group, Inc. | 5.55B | -0.45% | 18,397,658 | 3.22B |
| 155 | MANE | Veradermics, Incorporated | 5.47B | 3.37% | 1,114,026 | - |
| 156 | DOCS | Doximity, Inc. | 5.44B | 3.81% | 4,942,114 | 655.57M |
| 157 | ORKA | Oruka Therapeutics, Inc. | 5.44B | 6.25% | 1,206,680 | - |
| 158 | HAE | Haemonetics Corporation | 5.40B | -0.65% | 1,251,112 | 1.35B |
| 159 | PTCT | PTC Therapeutics, Inc. | 5.40B | 3.42% | 1,171,187 | 1.01B |
| 160 | COGT | Cogent Biosciences, Inc. | 5.38B | 3.06% | 2,520,464 | - |
| 161 | TFX | Teleflex Incorporated | 5.30B | 0.75% | 424,663 | 2.25B |
| 162 | STVN | Stevanato Group S.p.A. | 5.30B | 0.99% | 267,097 | 1.40B |
| 163 | MMSI | Merit Medical Systems, Inc. | 5.21B | 2.30% | 480,787 | 1.58B |
| 164 | CRSP | CRISPR Therapeutics AG | 5.16B | 5.85% | 1,472,030 | 13.39M |
| 165 | SHC | Sotera Health Company | 5.15B | 1.29% | 1,595,050 | 1.22B |
| 166 | SRRK | Scholar Rock Holding Corporation | 5.14B | -0.02% | 1,258,329 | - |
| 167 | WAY | Waystar Holding Corp. | 5.12B | 0.76% | 1,316,415 | 1.21B |
| 168 | DFTX | Definium Therapeutics, Inc. | 4.96B | 7.96% | 2,772,881 | - |
| 169 | TVTX | Travere Therapeutics, Inc. | 4.91B | 0.16% | 1,169,381 | 591.33M |
| 170 | LFST | LifeStance Health Group, Inc. | 4.75B | 2.99% | 1,799,510 | 1.58B |
| 171 | CON | Concentra Group Holdings Parent, Inc. | 4.74B | 1.58% | 1,064,050 | 2.29B |
| 172 | OPCH | Option Care Health, Inc. | 4.65B | 0.06% | 6,098,969 | 5.69B |
| 173 | BLLN | BillionToOne, Inc. | 4.63B | 2.81% | 325,026 | 397.41M |
| 174 | DNTH | Dianthus Therapeutics, Inc. | 4.61B | -0.07% | 738,267 | 1.90M |
| 175 | HTFL | HeartFlow, Inc. | 4.33B | 4.43% | 812,893 | 212.07M |
| 176 | ITGR | Integer Holdings Corporation | 4.30B | -0.03% | 1,439,780 | 1.84B |
| 177 | EWTX | Edgewise Therapeutics, Inc. | 4.24B | -0.43% | 1,062,489 | - |
| 178 | INDV | Indivior Pharmaceuticals, Inc. | 4.23B | 1.07% | 4,799,701 | 1.33B |
| 179 | ADPT | Adaptive Biotechnologies Corporation | 4.23B | 1.53% | 1,524,755 | 308.08M |
| 180 | LIVN | LivaNova PLC | 4.21B | 0.63% | 339,429 | 1.47B |
| 181 | ABCL | AbCellera Biologics Inc. | 4.07B | 4.37% | 4,691,319 | 66.17M |
| 182 | TNGX | Tango Therapeutics, Inc. | 4.01B | 5.49% | 3,098,811 | 53.81M |
| 183 | ICUI | ICU Medical, Inc. | 4.01B | 2.00% | 145,997 | 2.16B |
| 184 | RLAY | Relay Therapeutics, Inc. | 3.92B | 2.70% | 1,764,485 | 10.35M |
| 185 | PLSE | Pulse Biosciences, Inc. | 3.84B | 7.66% | 365,804 | 1.19M |
| 186 | TLX | Telix Pharmaceuticals Limited | 3.76B | 1.82% | 311,957 | 890.79M |
| 187 | NVST | Envista Holdings Corporation | 3.69B | 1.23% | 2,368,466 | 2.86B |
| 188 | RGC | Regencell Bioscience Holdings Limited | 3.64B | -3.67% | 118,675 | - |
| 189 | VCYT | Veracyte, Inc. | 3.64B | 3.74% | 966,521 | 561.90M |
| 190 | OGN | Organon & Co. | 3.63B | 0.44% | 3,264,912 | 6.13B |
| 191 | LEGN | Legend Biotech Corporation | 3.61B | -0.48% | 1,387,470 | 1.27B |
| 192 | NHC | National HealthCare Corporation | 3.56B | 0.86% | 62,819 | 1.56B |
| 193 | AMLX | Amylyx Pharmaceuticals, Inc. | 3.53B | 3.46% | 1,471,272 | -665.00K |
| 194 | XENE | Xenon Pharmaceuticals Inc. | 3.53B | 0.77% | 1,243,761 | 7.50M |
| 195 | IRTC | iRhythm Holdings, Inc. | 3.52B | 4.00% | 516,471 | 825.34M |
| 196 | IDYA | IDEAYA Biosciences, Inc. | 3.48B | 0.14% | 698,920 | 234.13M |
| 197 | ACAD | Acadia Pharmaceuticals Inc. | 3.41B | 1.02% | 1,470,244 | 1.14B |
| 198 | PBLS | Parabilis Medicines, Inc. | 3.39B | -2.17% | 1,086,557 | 148.00K |
| 199 | ARQT | Arcutis Biotherapeutics, Inc. | 3.34B | 8.53% | 1,731,706 | 463.98M |
| 200 | VKTX | Viking Therapeutics, Inc. | 3.33B | 2.81% | 4,045,849 | - |
| 201 | CELC | Celcuity Inc. | 3.32B | 0.10% | 1,277,551 | - |
| 202 | CDNA | CareDx, Inc. | 3.29B | 2.36% | 897,071 | 458.09M |
| 203 | TARS | Tarsus Pharmaceuticals, Inc. | 3.21B | 1.30% | 481,753 | 606.33M |
| 204 | WRBY | Warby Parker Inc. | 3.13B | 1.40% | 1,542,064 | 911.61M |
| 205 | DNLI | Denali Therapeutics Inc. | 3.11B | 4.18% | 1,340,697 | 3.60M |
| 206 | RCUS | Arcus Biosciences, Inc. | 3.11B | 2.43% | 795,186 | 117.00M |
| 207 | DYN | Dyne Therapeutics, Inc. | 3.11B | 1.65% | 3,564,860 | - |
| 208 | ELVN | Enliven Therapeutics, Inc. | 3.00B | 0.86% | 1,002,658 | - |
| 209 | ATRC | AtriCure, Inc. | 2.84B | 5.62% | 712,491 | 569.62M |
| 210 | ZLAB | Zai Lab Limited | 2.81B | 0.73% | 1,024,847 | 449.61M |
| 211 | PGEN | Precigen, Inc. | 2.80B | 2.76% | 3,384,174 | 85.72M |
| 212 | ACHC | Acadia Healthcare Company, Inc. | 2.72B | 2.70% | 1,383,726 | 3.37B |
| 213 | TMDX | TransMedics Group, Inc. | 2.70B | -1.43% | 733,651 | 668.47M |
| 214 | AVAH | Aveanna Healthcare Holdings Inc. | 2.67B | 0.08% | 1,680,824 | 2.60B |
| 215 | PRVA | Privia Health Group, Inc. | 2.66B | 3.27% | 1,128,385 | 2.36B |
| 216 | GRDN | Guardian Pharmacy Services, Inc. | 2.61B | -0.77% | 397,508 | 1.46B |
| 217 | NEOG | Neogen Corporation | 2.59B | 1.20% | 3,641,563 | 884.00M |
| 218 | NAMS | NewAmsterdam Pharma Company N.V. | 2.58B | 1.48% | 1,265,986 | 7.12M |
| 219 | BEAM | Beam Therapeutics Inc. | 2.57B | 4.47% | 1,801,584 | 156.04M |
| 220 | MBX | MBX Biosciences, Inc. | 2.56B | -0.02% | 538,783 | - |
| 221 | CLOV | Clover Health Investments, Corp. | 2.54B | 4.59% | 10,542,539 | 2.48B |
| 222 | SUPN | Supernus Pharmaceuticals, Inc. | 2.48B | 1.26% | 643,833 | 830.44M |
| 223 | LQDA | Liquidia Corporation | 2.45B | -2.28% | 3,616,929 | 450.91M |
| 224 | BKD | Brookdale Senior Living Inc. | 2.42B | -7.07% | 18,825,162 | 2.93B |
| 225 | IRON | Disc Medicine, Inc. | 2.38B | 2.12% | 691,135 | - |
| 226 | SLS | SELLAS Life Sciences Group, Inc. | 2.35B | 3.46% | 4,178,220 | - |
| 227 | CLDX | Celldex Therapeutics, Inc. | 2.35B | 2.01% | 992,608 | 158.00K |
| 228 | HRMY | Harmony Biosciences Holdings, Inc. | 2.35B | 1.72% | 487,061 | 959.90M |
| 229 | RXRX | Recursion Pharmaceuticals, Inc. | 2.34B | 10.38% | 35,501,287 | 54.86M |
| 230 | HCM | HUTCHMED (China) Limited | 2.33B | 3.15% | 50,068 | 549.12M |
| 231 | ADMA | ADMA Biologics, Inc. | 2.32B | 0.29% | 2,828,399 | 512.28M |
| 232 | NRIX | Nurix Therapeutics, Inc. | 2.32B | 0.63% | 1,525,470 | 36.77M |
| 233 | PBH | Prestige Consumer Healthcare Inc. | 2.28B | 0.75% | 323,704 | 1.10B |
| 234 | BHC | Bausch Health Companies Inc. | 2.26B | - | 1,032,826 | 10.85B |
| 235 | UFPT | UFP Technologies, Inc. | 2.24B | 0.84% | 92,649 | 631.64M |
| 236 | IMNM | Immunome, Inc. | 2.22B | 1.24% | 998,187 | 4.02M |
| 237 | AUPH | Aurinia Pharmaceuticals Inc. | 2.22B | 2.65% | 849,222 | 311.51M |
| 238 | BFLY | Butterfly Network, Inc. | 2.20B | 2.74% | 3,958,017 | 112.14M |
| 239 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.18B | 3.14% | 2,307,844 | 940.61M |
| 240 | PHVS | Pharvaris N.V. | 2.18B | -0.06% | 754,990 | - |
| 241 | VERA | Vera Therapeutics, Inc. | 2.15B | 0.50% | 996,574 | - |
| 242 | PGNY | Progyny, Inc. | 2.14B | 0.36% | 694,541 | 1.31B |
| 243 | AXGN | Axogen, Inc. | 2.12B | -0.14% | 929,754 | 251.17M |
| 244 | VRDN | Viridian Therapeutics, Inc. | 2.11B | 1.74% | 1,334,214 | 71.13M |
| 245 | MD | Pediatrix Medical Group, Inc. | 2.11B | 1.52% | 518,044 | 1.95B |
| 246 | NVAX | Novavax, Inc. | 2.10B | 15.80% | 19,026,371 | 413.80M |
| 247 | NEO | NeoGenomics, Inc. | 2.10B | 2.06% | 1,385,242 | 766.30M |
| 248 | ADUS | Addus HomeCare Corporation | 2.09B | 0.06% | 74,804 | 1.48B |
| 249 | PRGO | Perrigo Company plc | 2.09B | 3.86% | 4,396,699 | 4.14B |
| 250 | MLYS | Mineralys Therapeutics, Inc. | 2.07B | 4.42% | 895,149 | - |
| 251 | ALVO | Alvotech | 2.06B | 1.94% | 707,114 | 494.61M |
| 252 | TRLV | Trulieve Cannabis Corp. | 2.05B | 2.89% | 1,175,414 | 1.14B |
| 253 | VCEL | Vericel Corporation | 2.05B | 0.12% | 506,880 | 306.30M |
| 254 | SDGR | Schrödinger, Inc. | 2.04B | 3.37% | 2,080,247 | 259.04M |
| 255 | WGS | GeneDx Holdings Corp. | 2.01B | -0.59% | 405,104 | 454.43M |
| 256 | PVLA | Palvella Therapeutics, Inc. | 2.00B | 5.66% | 173,999 | - |
| 257 | ADRX | ADARx Pharmaceuticals, Inc. | 1.99B | 0.57% | 688,458 | 6.13M |
| 258 | INSP | Inspire Medical Systems, Inc. | 1.99B | 3.30% | 867,341 | 898.74M |
| 259 | FTRE | Fortrea Holdings Inc. | 1.98B | 2.31% | 931,304 | 2.68B |
| 260 | VIR | Vir Biotechnology, Inc. | 1.98B | 5.22% | 1,965,003 | 303.23M |
| 261 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.93B | 3.19% | 2,306,189 | 208.78M |
| 262 | ASTH | Astrana Health, Inc. | 1.92B | 4.68% | 317,047 | 3.84B |
| 263 | LKFT | Lakefront Biotherapeutics NV | 1.92B | 0.75% | 212,541 | 1.13B |
| 264 | XERS | Xeris Biopharma Holdings, Inc. | 1.91B | 2.85% | 2,712,285 | 335.41M |
| 265 | AGIO | Agios Pharmaceuticals, Inc. | 1.90B | -0.34% | 835,681 | 98.34M |
| 266 | SRPT | Sarepta Therapeutics, Inc. | 1.89B | -1.98% | 3,015,043 | 1.97B |
| 267 | TRVI | Trevi Therapeutics, Inc. | 1.88B | 2.85% | 5,029,873 | - |
| 268 | LMAT | LeMaitre Vascular, Inc. | 1.85B | 1.32% | 126,705 | 262.43M |
| 269 | GENB | Generate Biomedicines, Inc. | 1.84B | 2.50% | 903,353 | 26.48M |
| 270 | ESTA | Establishment Labs Holdings Inc. | 1.84B | 1.75% | 299,546 | 245.82M |
| 271 | NTLA | Intellia Therapeutics, Inc. | 1.83B | 3.73% | 8,154,715 | 59.51M |
| 272 | XNCR | Xencor, Inc. | 1.83B | 0.53% | 1,145,230 | 104.97M |
| 273 | ZYME | Zymeworks Inc. | 1.83B | 2.10% | 491,135 | 37.13M |
| 274 | BHVN | Biohaven Ltd. | 1.82B | 1.26% | 1,370,052 | - |
| 275 | GPCR | Structure Therapeutics Inc. | 1.82B | -0.51% | 593,230 | - |
| 276 | MESO | Mesoblast Limited | 1.81B | 3.93% | 178,169 | 120.25M |
| 277 | SGRY | Surgery Partners, Inc. | 1.80B | 1.83% | 929,005 | 3.37B |
| 278 | URGN | UroGen Pharma Ltd. | 1.80B | -0.41% | 3,895,594 | 188.73M |
| 279 | SEPN | Septerna, Inc. | 1.79B | 3.98% | 349,375 | 98.88M |
| 280 | ZBIO | Zenas BioPharma, Inc. | 1.78B | 3.89% | 429,816 | 1.00M |
| 281 | XRAY | DENTSPLY SIRONA Inc. | 1.76B | 1.61% | 4,219,713 | 3.64B |
| 282 | NUVB | Nuvation Bio Inc. | 1.76B | 1.01% | 2,957,047 | 169.90M |
| 283 | ALMR | Alamar Biosciences, Inc. | 1.75B | -2.47% | 1,133,558 | 100.42M |
| 284 | ABSI | Absci Corporation | 1.74B | 13.65% | 4,245,312 | 1.56M |
| 285 | PSNL | Personalis, Inc. | 1.71B | -0.37% | 1,835,887 | 69.67M |
| 286 | NVCR | NovoCure Limited | 1.70B | 2.53% | 1,022,286 | 699.19M |
| 287 | FRNM | Freenome, Inc. | 1.70B | -0.19% | 558,748 | 35.41M |
| 288 | SNDA | Sonida Senior Living, Inc. | 1.67B | -2.00% | 579,051 | 481.07M |
| 289 | CMPS | COMPASS Pathways plc | 1.66B | 4.62% | 2,282,987 | - |
| 290 | OCUL | Ocular Therapeutix, Inc. | 1.66B | 0.40% | 2,630,475 | 52.06M |
| 291 | AZTA | Azenta, Inc. | 1.65B | 4.78% | 1,163,063 | 613.81M |
| 292 | ATEC | Alphatec Holdings, Inc. | 1.65B | 3.09% | 1,565,259 | 815.05M |
| 293 | BRVE | Braveheart Bio, Inc. | 1.63B | 4.87% | 255,238 | - |
| 294 | OMCL | Omnicell, Inc. | 1.63B | 2.84% | 303,068 | 1.25B |
| 295 | KMTS | Kestra Medical Technologies, Ltd. | 1.61B | 4.70% | 246,775 | 106.73M |
| 296 | STOK | Stoke Therapeutics, Inc. | 1.60B | 3.30% | 918,955 | 27.59M |
| 297 | ARDT | Ardent Health, Inc. | 1.59B | 2.08% | 568,331 | 6.41B |
| 298 | ANIP | ANI Pharmaceuticals, Inc. | 1.58B | 2.65% | 540,837 | 978.38M |
| 299 | ETON | Eton Pharmaceuticals, Inc. | 1.58B | 0.84% | 370,776 | 105.60M |
| 300 | QURE | uniQure N.V. | 1.57B | 0.22% | 1,513,332 | 18.67M |
| 301 | ALHC | Alignment Healthcare, Inc. | 1.57B | -13.38% | 26,160,419 | 4.58B |
| 302 | PAHC | Phibro Animal Health Corporation | 1.56B | 2.41% | 235,912 | 1.52B |
| 303 | KRSA | Korsana Biosciences, Inc. | 1.54B | 1.22% | 45,915 | - |
| 304 | INVA | Innoviva, Inc. | 1.53B | 1.63% | 507,581 | 440.00M |
| 305 | RARE | Ultragenyx Pharmaceutical Inc. | 1.52B | 1.24% | 2,927,349 | 717.00M |
| 306 | SNDX | Syndax Pharmaceuticals, Inc. | 1.52B | 0.53% | 1,459,036 | 252.25M |
| 307 | IMCR | Immunocore Holdings plc | 1.51B | 1.03% | 452,838 | 430.78M |
| 308 | MAZE | Maze Therapeutics, Inc. | 1.51B | 4.75% | 670,918 | 20.00M |
| 309 | KLRA | Kailera Therapeutics, Inc. | 1.51B | 16.10% | 2,182,264 | - |
| 310 | COAG | Hemab Therapeutics Holdings, Inc. | 1.48B | 2.36% | 619,014 | - |
| 311 | RAPP | Rapport Therapeutics, Inc. | 1.47B | 2.68% | 247,879 | 20.00M |
| 312 | TSHA | Taysha Gene Therapies, Inc. | 1.46B | 1.35% | 5,382,787 | 5.49M |
| 313 | GHRS | GH Research PLC | 1.45B | 3.23% | 146,040 | - |
| 314 | PCRX | Pacira BioSciences, Inc. | 1.45B | -0.22% | 4,690,149 | 746.16M |
| 315 | OMER | Omeros Corporation | 1.44B | 3.71% | 793,925 | 38.42M |
| 316 | AMN | AMN Healthcare Services, Inc. | 1.41B | 3.05% | 428,636 | 3.43B |
| 317 | HCSG | Healthcare Services Group, Inc. | 1.41B | -0.34% | 446,297 | 1.86B |
| 318 | NUTX | Nutex Health Inc. | 1.41B | 0.62% | 170,911 | 846.72M |
| 319 | NKTR | Nektar Therapeutics | 1.41B | 0.91% | 1,174,737 | 54.59M |
| 320 | INBX | Inhibrx Biosciences, Inc. | 1.40B | 2.43% | 86,817 | 1.30M |
| 321 | CERT | Certara, Inc. | 1.39B | 5.67% | 5,034,086 | 421.75M |
| 322 | PNTG | The Pennant Group, Inc. | 1.39B | -1.59% | 321,426 | 1.10B |
| 323 | AGL | agilon health, inc. | 1.38B | -2.75% | 171,880 | 5.92B |
| 324 | ANAB | AnaptysBio, Inc. | 1.37B | -0.56% | 495,669 | 106.09M |
| 325 | KARD | Kardigan, Inc. | 1.37B | 3.31% | 740,189 | - |
| 326 | TYRA | Tyra Biosciences, Inc. | 1.37B | -0.15% | 649,438 | - |
| 327 | DRTS | Alpha Tau Medical Ltd. | 1.33B | 2.93% | 368,171 | - |
| 328 | CNMD | CONMED Corporation | 1.33B | -1.53% | 400,451 | 1.37B |
| 329 | AAPG | Ascentage Pharma Group International | 1.32B | 1.37% | 1,198 | 94.61M |
| 330 | OMDA | Omada Health, Inc. | 1.32B | 3.51% | 836,748 | 309.76M |
| 331 | DMRA | Damora Therapeutics, Inc. | 1.30B | 2.53% | 368,607 | - |
| 332 | REPL | Replimune Group, Inc. | 1.26B | 2.91% | 2,016,346 | - |
| 333 | USPH | U.S. Physical Therapy, Inc. | 1.26B | 1.38% | 143,467 | 804.27M |
| 334 | SVRA | Savara Inc. | 1.25B | 1.86% | 1,529,138 | - |
| 335 | ORIC | ORIC Pharmaceuticals, Inc. | 1.24B | -0.33% | 1,086,581 | - |
| 336 | INNV | InnovAge Holding Corp. | 1.24B | -0.11% | 343,063 | 989.71M |
| 337 | NBTX | Nanobiotix S.A. | 1.21B | 3.41% | 93,496 | 13.15M |
| 338 | LBRX | LB Pharmaceuticals Inc | 1.20B | 7.54% | 642,580 | - |
| 339 | CRON | Cronos Group Inc. | 1.19B | 0.31% | 414,036 | 179.09M |
| 340 | VOR | Vor Biopharma Inc. | 1.18B | 4.03% | 1,102,364 | - |
| 341 | GDRX | GoodRx Holdings, Inc. | 1.17B | 2.08% | 610,614 | 785.23M |
| 342 | BCAX | Bicara Therapeutics Inc. | 1.16B | 1.39% | 715,972 | - |
| 343 | AVLN | Avalyn Pharma Inc. | 1.14B | 0.16% | 241,836 | - |
| 344 | TRAX | First Tracks Biotherapeutics, Inc. | 1.14B | -0.50% | 855,238 | - |
| 345 | AMPH | Amphastar Pharmaceuticals, Inc. | 1.13B | 3.14% | 437,696 | 730.02M |
| 346 | JANX | Janux Therapeutics, Inc. | 1.12B | -0.59% | 1,172,963 | 24.00M |
| 347 | TNDM | Tandem Diabetes Care, Inc. | 1.12B | 2.74% | 1,431,356 | 1.04B |
| 348 | IRMD | IRADIMED CORPORATION | 1.12B | 1.84% | 68,873 | 86.34M |
| 349 | HROW | Harrow, Inc. | 1.10B | -3.80% | 1,352,143 | 275.59M |
| 350 | BVS | Bioventus Inc. | 1.10B | 2.96% | 273,320 | 581.85M |
| 351 | STAA | STAAR Surgical Company | 1.09B | -3.17% | 592,496 | 339.59M |
| 352 | AHG | Akso Health Group | 1.07B | 9.65% | 21,138 | 13.83M |
| 353 | LTGO | Latigo Biotherapeutics, Inc. | 1.06B | 8.18% | 184,215 | - |
| 354 | MNKD | MannKind Corporation | 1.06B | -3.80% | 4,549,635 | 393.63M |
| 355 | PRCT | PROCEPT BioRobotics Corporation | 1.05B | 2.79% | 1,114,122 | 337.34M |
| 356 | CSTL | Castle Biosciences, Inc. | 1.05B | 2.11% | 249,075 | 357.28M |
| 357 | TDOC | Teladoc Health, Inc. | 1.05B | 4.15% | 4,186,149 | 2.49B |
| 358 | IART | Integra LifeSciences Holdings Corporation | 1.05B | 0.22% | 1,228,147 | 1.65B |
| 359 | AORT | Artivion, Inc. | 1.04B | 0.24% | 343,497 | 471.47M |
| 360 | OPK | OPKO Health, Inc. | 1.03B | 0.73% | 1,093,579 | 587.90M |
| 361 | MGTX | MeiraGTx Holdings plc | 1.03B | 1.81% | 523,431 | 397.50M |
| 362 | ENOV | Enovis Corporation | 1.02B | 1.49% | 1,146,631 | 2.30B |
| 363 | IMTX | Immatics N.V. | 1.02B | 0.81% | 1,371,277 | 47.65M |
| 364 | HSTM | HealthStream, Inc. | 1.01B | 2.03% | 217,974 | 321.12M |
| 365 | LMRI | Lumexa Imaging Holdings, Inc. | 1.01B | 2.03% | 370,852 | 1.04B |
| 366 | AKTS | Aktis Oncology, Inc. | 1.01B | 2.31% | 361,042 | 10.06M |
| 367 | ANL | Adlai Nortye Group Ltd. | 1.01B | 0.71% | 300,392 | 18.06M |
| 368 | CGEM | Cullinan Therapeutics, Inc. | 999.43M | 0.45% | 567,509 | - |
| 369 | SPTX | Seaport Therapeutics, Inc. | 971.58M | 1.34% | 171,205 | - |
| 370 | ANRO | Alto Neuroscience, Inc. | 956.33M | 1.41% | 649,427 | - |
| 371 | KURA | Kura Oncology, Inc. | 942.98M | 0.76% | 1,473,708 | 77.23M |
| 372 | BBNX | Beta Bionics, Inc. | 928.08M | 1.15% | 955,103 | 119.01M |
| 373 | ALMS | Alumis Inc. | 926.76M | 2.73% | 1,371,009 | 7.40M |
| 374 | MLTX | MoonLake Immunotherapeutics | 920.85M | 2.27% | 2,010,972 | - |
| 375 | QDEL | QuidelOrtho Corporation | 920.28M | 8.14% | 3,576,902 | 2.67B |
| 376 | RIGL | Rigel Pharmaceuticals, Inc. | 916.81M | 0.74% | 279,361 | 276.79M |
| 377 | JBIO | Jade Biosciences, Inc. | 915.17M | 1.70% | 735,510 | - |
| 378 | ODTX | Odyssey Therapeutics, Inc. | 910.45M | 4.86% | 325,592 | 99.00K |
| 379 | CBLL | CeriBell, Inc. | 906.87M | 2.07% | 325,341 | 101.96M |
| 380 | CRVS | Corvus Pharmaceuticals, Inc. | 884.95M | 3.04% | 1,031,889 | - |
| 381 | GLUE | Monte Rosa Therapeutics, Inc. | 878.73M | -0.19% | 1,201,733 | 28.73M |
| 382 | DNA | Ginkgo Bioworks Holdings, Inc. | 875.42M | 14.64% | 4,519,949 | 132.42M |
| 383 | SIBN | SI-BONE, Inc. | 868.14M | 2.70% | 555,905 | 213.60M |
| 384 | HELP | Helus Pharma Inc. | 862.11M | 10.07% | 1,664,669 | - |
| 385 | SLBT | SL Science Holding Limited | 861.10M | -0.66% | 25,118 | 3.27M |
| 386 | SANA | Sana Biotechnology, Inc. | 835.22M | - | 2,918,304 | - |
| 387 | ABUS | Arbutus Biopharma Corporation | 834.92M | 0.96% | 3,146,174 | 181.72M |
| 388 | SGP | SpyGlass Pharma, Inc. | 833.52M | 1.22% | 68,252 | - |
| 389 | AVBP | ArriVent BioPharma, Inc. | 824.92M | 0.12% | 1,731,729 | - |
| 390 | ARDX | Ardelyx, Inc. | 817.34M | 0.31% | 2,357,788 | 450.89M |
| 391 | INMD | InMode Ltd. | 816.80M | 0.92% | 289,906 | 374.63M |
| 392 | AHCO | AdaptHealth Corp. | 808.46M | -0.16% | 1,456,054 | 3.36B |
| 393 | GMRS | GMR Solutions Inc. | 806.75M | -1.52% | 1,273,007 | 5.88B |
| 394 | OBX | Obsidian Therapeutics, Inc. | 803.05M | 6.21% | 532,193 | - |
| 395 | GERN | Geron Corporation | 787.03M | 0.41% | 5,639,845 | 204.56M |
| 396 | IMMX | Immix Biopharma, Inc. | 784.26M | 1.83% | 1,109,037 | - |
| 397 | VREX | Varex Imaging Corporation | 778.05M | -0.05% | 237,362 | 865.00M |
| 398 | APMD | Apnimed, Inc. | 771.00M | 1.65% | 268,250 | 115.12M |
| 399 | ACHV | Achieve Life Sciences, Inc. | 762.51M | 3.06% | 986,708 | - |
| 400 | ANNX | Annexon, Inc. | 762.11M | 0.50% | 2,385,018 | - |
| 401 | CADL | Candel Therapeutics, Inc. | 760.59M | 2.90% | 718,128 | - |
| 402 | VSTM | Verastem, Inc. | 758.92M | 3.33% | 2,970,338 | 87.53M |
| 403 | IVA | Inventiva S.A. | 756.65M | -4.82% | 2,788,754 | 2.81M |
| 404 | LXRX | Lexicon Pharmaceuticals, Inc. | 747.53M | -4.55% | 2,067,692 | 41.47M |
| 405 | GYRE | Gyre Therapeutics, Inc. | 746.48M | 4.14% | 76,632 | 109.82M |
| 406 | ATTO | Attovia Therapeutics, Inc. | 740.01M | -0.61% | 194,180 | 1.80M |
| 407 | SLDB | Solid Biosciences Inc. | 736.64M | 0.73% | 726,721 | - |
| 408 | FDMT | 4D Molecular Therapeutics, Inc. | 736.41M | 4.96% | 867,987 | 92.01M |
| 409 | AVTX | Avalo Therapeutics, Inc. | 732.05M | 1.64% | 648,577 | 59.00K |
| 410 | DSGN | Design Therapeutics, Inc. | 729.08M | 1.39% | 356,593 | - |
| 411 | PACB | Pacific Biosciences of California, Inc. | 724.24M | 1.30% | 12,816,164 | 159.27M |
| 412 | COLL | Collegium Pharmaceutical, Inc. | 719.15M | -0.09% | 438,339 | 808.21M |
| 413 | PRME | Prime Medicine, Inc. | 709.84M | 11.45% | 8,066,135 | 4.07M |
| 414 | CTKB | Cytek Biosciences, Inc. | 705.81M | 1.31% | 3,883,903 | 206.71M |
| 415 | OABI | OmniAb, Inc. | 696.42M | 2.79% | 1,039,170 | 38.46M |
| 416 | PHAR | Pharming Group N.V. | 694.55M | 2.73% | 3,331 | 366.48M |
| 417 | NVCT | Nuvectis Pharma, Inc. | 688.12M | 4.92% | 152,958 | - |
| 418 | OLMA | Olema Pharmaceuticals, Inc. | 684.23M | - | 758,248 | - |
| 419 | WVE | Wave Life Sciences, Inc. | 681.79M | -0.29% | 1,655,983 | 65.37M |
| 420 | MDXG | MiMedx Group, Inc. | 680.70M | 1.08% | 391,112 | 355.17M |
| 421 | AURA | Aura Biosciences, Inc. | 678.23M | 0.46% | 962,556 | - |
| 422 | ZVRA | Zevra Therapeutics, Inc. | 676.38M | 3.55% | 730,642 | 136.07M |
| 423 | STLN | Starling Oncology, Inc. | 675.70M | 7.28% | 1,848,307 | 587.24M |
| 424 | FTH | Faeth Therapeutics, Inc. | 672.63M | 1.64% | 197,135 | - |
| 425 | PHR | Phreesia, Inc. | 670.99M | 1.41% | 537,070 | 507.79M |
| 426 | AVR | Anteris Technologies Global Corp. | 660.03M | 2.11% | 1,344,046 | 2.24M |
| 427 | CBIO | Crescent Biopharma, Inc. | 638.16M | 5.59% | 347,123 | 11.88M |
| 428 | SGMT | Sagimet Biosciences Inc. | 633.21M | 0.11% | 763,530 | - |
| 429 | CLYM | Climb Bio, Inc. | 631.80M | 1.29% | 638,138 | - |
| 430 | IRWD | Ironwood Pharmaceuticals, Inc. | 631.22M | -1.29% | 1,721,342 | 389.32M |
| 431 | SOPH | SOPHiA GENETICS SA | 630.80M | 1.51% | 328,117 | 86.17M |
| 432 | AQST | Aquestive Therapeutics, Inc. | 599.95M | 0.42% | 1,691,550 | 54.09M |
| 433 | STTK | Shattuck Labs, Inc. | 599.17M | 5.48% | 1,049,337 | 1.00M |
| 434 | FLGT | Fulgent Genetics, Inc. | 598.18M | 4.42% | 253,935 | 323.93M |
| 435 | SLN | Silence Therapeutics plc | 593.66M | 3.57% | 844,344 | 615.00K |
| 436 | WEAV | Weave Communications, Inc. | 590.39M | -0.14% | 3,375,158 | 257.79M |
| 437 | PHAT | Phathom Pharmaceuticals, Inc. | 575.87M | 1.68% | 928,338 | 239.66M |
| 438 | CRMD | CorMedix Inc. | 575.23M | 0.82% | 1,257,046 | 462.25M |
| 439 | ETRA | Electra Therapeutics, Inc. | 567.41M | -1.09% | 778,360 | - |
| 440 | KIDS | OrthoPediatrics Corp. | 565.28M | -0.51% | 135,532 | 252.72M |
| 441 | ACRS | Aclaris Therapeutics, Inc. | 563.77M | 1.06% | 5,060,057 | 8.22M |
| 442 | CTMX | CytomX Therapeutics, Inc. | 560.00M | 4.05% | 3,040,160 | 18.30M |
| 443 | DBVT | DBV Technologies S.A. | 555.98M | 2.62% | 324,016 | 5.04M |
| 444 | BLSM | BlossomHill Therapeutics, Inc. | 555.60M | 3.55% | 131,828 | - |
| 445 | EVO | Evotec SE | 550.90M | -2.55% | 40,004 | 819.47M |
| 446 | VALN | Valneva SE | 537.87M | 1.58% | 5,605 | 163.30M |
| 447 | DRUG | Bright Minds Biosciences Inc. | 533.01M | 3.94% | 98,401 | - |
| 448 | DCTH | Delcath Systems, Inc. | 532.97M | 2.13% | 190,108 | 95.42M |
| 449 | RGNX | REGENXBIO Inc. | 532.73M | -0.25% | 859,286 | 174.48M |
| 450 | PBYI | Puma Biotechnology, Inc. | 531.17M | 3.21% | 303,060 | 231.24M |
| 451 | SSII | SS Innovations International, Inc. | 530.02M | 0.57% | 45,413 | 52.40M |
| 452 | MNPR | Monopar Therapeutics Inc. | 529.99M | -5.98% | 135,845 | - |
| 453 | NGNE | Neurogene Inc. | 528.30M | -0.38% | 465,832 | 925.00K |
| 454 | PROK | ProKidney Corp. | 526.04M | 4.82% | 1,385,948 | 818.00K |
| 455 | TLRY | Tilray Brands, Inc. | 519.19M | -1.39% | 5,727,981 | 963.10M |
| 456 | OCS | Oculis Holding AG | 514.85M | -3.70% | 162,060 | 1.45M |
| 457 | RZLT | Rezolute, Inc. | 510.85M | 4.96% | 1,873,613 | - |
| 458 | EOLS | Evolus, Inc. | 510.57M | -0.90% | 429,869 | 316.49M |
| 459 | TCMD | Tactile Systems Technology, Inc. | 508.32M | 1.45% | 136,694 | 350.31M |
| 460 | ALT | Altimmune, Inc. | 507.69M | 0.38% | 2,677,674 | 31.00K |
| 461 | ALLO | Allogene Therapeutics, Inc. | 504.42M | 4.29% | 10,605,411 | 4.64M |
| 462 | MCTA | Charming Medical Limited | 504.26M | -0.85% | - | 4.81M |
| 463 | CTNM | Contineum Therapeutics, Inc. | 503.37M | 1.52% | 885,578 | - |
| 464 | ARVN | Arvinas, Inc. | 499.55M | 1.73% | 559,960 | 316.70M |
| 465 | MASS | 908 Devices Inc. | 498.07M | 4.33% | 323,078 | 60.84M |
| 466 | EPRX | Eupraxia Pharmaceuticals Inc. | 491.01M | -1.45% | 1,051,830 | - |
| 467 | MPLT | MapLight Therapeutics, Inc. | 490.73M | -3.50% | 495,282 | - |
| 468 | SGHT | Sight Sciences, Inc. | 489.73M | 4.96% | 289,455 | 83.38M |
| 469 | ANGO | AngioDynamics, Inc. | 484.47M | 2.58% | 2,156,059 | 325.38M |
| 470 | AUTL | Autolus Therapeutics plc | 481.75M | 2.26% | 1,476,329 | 117.39M |
| 471 | OVID | Ovid Therapeutics Inc. | 480.43M | 5.13% | 1,406,675 | 1.58M |
| 472 | ASMB | Assembly Biosciences, Inc. | 479.08M | 3.11% | 170,465 | 74.85M |
| 473 | YDES | YD Bio Limited | 476.69M | 16.23% | 207,769 | 1.24M |
| 474 | SENS | Senseonics Holdings, Inc. | 474.81M | -0.44% | 499,321 | 48.55M |
| 475 | TKNO | Alpha Teknova, Inc. | 474.60M | 4.74% | 195,288 | 43.70M |
| 476 | KMDA | Kamada Ltd. | 464.95M | 3.86% | 72,411 | 191.85M |
| 477 | CERS | Cerus Corporation | 463.51M | 0.88% | 787,799 | 221.55M |
| 478 | BWAY | BrainsWay Ltd. | 463.34M | 2.62% | 104,053 | 60.70M |
| 479 | ENTX | Entera Bio Ltd. | 460.56M | 6.40% | 1,584,050 | 42.00K |
| 480 | EVH | Evolent Health, Inc. | 456.76M | 2.02% | 1,068,783 | 2.10B |
| 481 | TECX | Tectonic Therapeutic, Inc. | 456.09M | 2.55% | 110,712 | - |
| 482 | CAPR | Capricor Therapeutics, Inc. | 455.23M | -2.25% | 1,697,662 | 11.13M |
| 483 | PRTA | Prothena Corporation plc | 453.82M | 2.67% | 931,618 | 54.53M |
| 484 | NRC | NRC Health | 449.69M | -0.44% | 52,562 | 140.00M |
| 485 | DMAC | DiaMedica Therapeutics Inc. | 449.20M | 4.00% | 170,151 | - |
| 486 | AGMB | AgomAb Therapeutics NV | 447.17M | -1.52% | 102,314 | - |
| 487 | EDIT | Editas Medicine, Inc. | 445.38M | 2.11% | 3,086,658 | 47.01M |
| 488 | NPCE | NeuroPace, Inc. | 434.89M | 2.26% | 72,636 | 106.99M |
| 489 | SPRY | ARS Pharmaceuticals, Inc. | 420.66M | -7.24% | 1,258,394 | 116.93M |
| 490 | CTEV | Claritev Corporation | 417.92M | 1.36% | 126,752 | 994.67M |
| 491 | AVIR | Atea Pharmaceuticals, Inc. | 413.05M | -0.19% | 157,965 | - |
| 492 | MYGN | Myriad Genetics, Inc. | 412.25M | 2.62% | 1,367,872 | 806.60M |
| 493 | RCEL | AVITA Medical, Inc. | 408.54M | -0.90% | 280,230 | 75.63M |
| 494 | EIKN | Eikon Therapeutics, Inc. | 404.61M | -0.40% | 288,688 | - |
| 495 | GLAS | Glass House Brands Inc. | 401.47M | -3.40% | 1,842,354 | 176.98M |
| 496 | SCTX | Scribe Therapeutics Inc. | 400.78M | 10.09% | 396,955 | 33.30M |
| 497 | SRTA | Strata Critical Medical, Inc. | 400.75M | 1.34% | 623,105 | 255.98M |
| 498 | PRLD | Prelude Therapeutics Incorporated | 400.65M | 0.26% | 341,643 | 22.42M |
| 499 | GALT | Galectin Therapeutics Inc. | 397.35M | 8.24% | 156,405 | - |
| 500 | KYTX | Kyverna Therapeutics, Inc. | 395.18M | 3.40% | 876,391 | - |